Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
AAAS Promotion

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 16 June 1989:
Vol. 244. no. 4910, pp. 1275 - 1281
DOI: 10.1126/science.2660259
Prev | Table of Contents | Next

Articles

Science, Vol 244, Issue 4910, 1275-1281
Copyright © 1989 by American Association for the Advancement of Science

articles

Progress toward human gene therapy

T Friedmann

Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla 92093.

Current therapies for most human genetic diseases are inadequate. In response to the need for effective treatments, modern molecular genetics is providing tools for an unprecedented new approach to disease treatment through an attack directly on mutant genes. Recent results with several target organs and gene transfer techniques have led to broad medical and scientific acceptance of the feasibility of this "gene therapy" concept for disorders of the bone marrow, liver, and central nervous system; some kinds of cancer; and deficiencies of circulating enzymes, hormones, and coagulation factors. The most well-developed models involve alteration of mutant target genes by gene transfer with recombinant pathogenic viruses in order to express new genetic information and to correct disease phenotypes--the conversion of the swords of pathology into the plowshares of therapy.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo.
X. Li, Y. Pan, R. Fan, H. Jin, S. Han, J. Liu, K. Wu, and D. Fan (2008)
Carcinogenesis 29, 1587-1593
   Abstract »    Full Text »    PDF »
Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo.
S.-Z. Zhang, F.-Y. Pan, J.-F. Xu, J. Yuan, S.-Y. Guo, G. Dai, B. Xue, W.-G. Shen, C.-J. Wen, D.-H. Zhao, et al. (2005)
Mol. Cancer Ther. 4, 1577-1584
   Abstract »    Full Text »    PDF »
Locus Control Region of the Human CD2 Gene in a Lentivirus Vector Confers Position-Independent Transgene Expression.
C. M. Kowolik, J. Hu, and J.-K. Yee (2001)
J. Virol. 75, 4641-4648
   Abstract »    Full Text »
Synthetic Hydrogels as Carriers in Antisense Therapy: Preliminary Evaluation of an Oligodeoxynucleotide Covalent Conjugate with a Copolymer of 1-Vinyl-2-Pyrrolidinone and 2-Hydroxyethyl Methacrylate.
X. Lou, K. L. Garrett, P. E. Rakoczy, and T. V. Chirila (2001)
J Biomater Appl 15, 307-320
   Abstract »    PDF »
Synthesis and Evaluation of Poly(Ethylene Glycol)-Polylysine Block Copolymers as Carriers for Gene Delivery.
S. Vanderkerken, T. Vanheede, V. Toncheva, E. Schacht, M. A. Wolfert, L. Seymour, and A. Urtti (2000)
Journal of Bioactive and Compatible Polymers 15, 115-138
   Abstract »    PDF »
The Role of the Toxicologic Pathologist in the Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals.
A. M. Pilling (1999)
Toxicol Pathol 27, 678-688
   Abstract »    PDF »
A Double Recombinant Adenovirus Expressing the Costimulatory Molecule B7-1 (Murine) and Human IL-2 Induces Complete Tumor Regression in a Murine Breast Adenocarcinoma Model.
P. C. R. Emtage, Y. Wan, J. L. Bramson, F. L. Graham, and J. Gauldie (1998)
J. Immunol. 160, 2531-2538
   Abstract »    Full Text »    PDF »
Glucose-Stimulated Genes and Prospects of Gene Therapy for Type I Diabetes.
D. Mitanchez, B. Doiron, R. Chen, and A. Kahn (1997)
Endocr. Rev. 18, 520-540
   Abstract »    Full Text »    PDF »
Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA- Immunodeficient Patients.
C. Bordignon, L. D. Notarangelo, N. Nobili, G. Ferrari, G. Casorati, P. Panina, E. Mazzolari, D. Maggioni, C. Rossi, P. Servida, et al. (1995)
Science 270, 470-475
   Abstract »    PDF »
Potential Gene Therapy Strategies in the Treatment of Cardiovascular Disease.
R. T. Rowland, J. C. Cleveland Jr, X. Meng, A. H. Harken, and J. M. Brown (1995)
Ann. Thorac. Surg. 60, 721-728
   Abstract »    Full Text »
Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery.
E. Raz, J. Dudler, M. Lotz, S.M. Baird, C.C. Berry, R.A. Eisenberg, and D.A. Carson (1995)
Lupus 4, 286-292
   Abstract »    PDF »
Human gene therapy.
W. Anderson (1992)
Science 256, 808-813
   Abstract »    PDF »
Systemic delivery of human growth hormone by injection of genetically engineered myoblasts.
J Dhawan, L. Pan, G. Pavlath, M. Travis, A. Lanctot, and H. Blau (1991)
Science 254, 1509-1512
   Abstract »    PDF »
An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency.
G Ferrari, S Rossini, R Giavazzi, D Maggioni, N Nobili, M Soldati, G Ungers, F Mavilio, E Gilboa, and C Bordignon (1991)
Science 251, 1363-1366
   Abstract »    PDF »
Correction of CD18-deficient lymphocytes by retrovirus-mediated gene transfer.
J. Wilson, A. Ping, J. Krauss, L Mayo-Bond, C. Rogers, D. Anderson, and R. Todd (1990)
Science 248, 1413-1416
   Abstract »    PDF »
Direct gene transfer into mouse muscle in vivo.
J. Wolff, R. Malone, P Williams, W Chong, G Acsadi, A Jani, and P. Felgner (1990)
Science 247, 1465-1468
   Abstract »    PDF »
Retrovirus vectors: promise and reality.
H. Temin (1989)
Science 246, 983
   PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)